CBFP
TMO icon

Cedar Brook Financial Partners’s Thermo Fisher Scientific TMO Stock Holding History

Cedar Brook Financial Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,035
Closed -$602K – 367
2024
Q1 		$602K Buy
1,035
+25
+2% +$14K 0.12% 181
2023
Q4 		$551K Buy
1,010
+388
+62% +$188K 0.12% 181
2023
Q3 		$315K Sell
622
-79
-11% -$42.1K 0.08% 246
2023
Q2 		$365K Sell
701
-25
-3% -$13.5K 0.09% 239
2023
Q1 		$419K Buy
726
+24
+3% +$13.5K 0.11% 205
2022
Q4 		$387K Sell
702
-19
-3% -$10.1K 0.11% 209
2022
Q3 		$366K Buy
721
+38
+6% +$21.3K 0.12% 207
2022
Q2 		$371K Buy
683
+88
+15% +$48.4K 0.12% 204
2022
Q1 		$351K Buy
595
+59
+11% +$33.9K 0.09% 237
2021
Q4 		$357K Buy
536
+34
+7% +$21.2K 0.09% 242
2021
Q3 		$287K Sell
502
-34
-6% -$18.7K 0.09% 255
2021
Q2 		$271K Buy
536
+43
+9% +$20.3K 0.08% 292
2021
Q1 		$225K Sell
493
-6
-1% -$2.86K 0.08% 287
2020
Q4 		$232K Sell
499
-66
-12% -$30.9K 0.08% 277
2020
Q3 		$249K Sell
565
-4
-0.7% -$1.65K 0.1% 234
2020
Q2 		$206K Buy
+569
New +$191K 0.09% 258

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cedar Brook Financial Partners's TMO Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 1,035 shares — an estimated $602K sold.

Cedar Brook Financial Partners first reported a position in TMO in Q2 2020 and held it in 16 quarters. The position peaked at $602K in Q1 2024. 2,548 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Cedar Brook Financial Partners reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 1,035 Thermo Fisher Scientific shares in Q2 2024, an estimated $602K.
  • Cedar Brook Financial Partners first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 16 quarters.
  • Cedar Brook Financial Partners's Thermo Fisher Scientific position peaked at $602K in Q1 2024.
  • 2,548 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.